<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T06:10:52Z</responseDate>
  <request identifier="oai:figshare.com:article/34047373" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34047373</identifier>
        <datestamp>2026-10-01T17:22:56Z</datestamp>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Bat sarbecovirus usage of mammalian ACE2.&lt;/p&gt;</dc:title>
          <dc:creator>Nazia Thakur (9904162)</dc:creator>
          <dc:creator>Joseph Newman (5638340)</dc:creator>
          <dc:creator>Dongchun Ni (15188356)</dc:creator>
          <dc:creator>Jeffrey Seow (9415776)</dc:creator>
          <dc:creator>Abigail L. Hay (25157576)</dc:creator>
          <dc:creator>Yeonjae Lee (12256119)</dc:creator>
          <dc:creator>Ayush Upadhyay (25157573)</dc:creator>
          <dc:creator>Babatunde E. Ekundayo (25157578)</dc:creator>
          <dc:creator>John A. Hammond (7431785)</dc:creator>
          <dc:creator>Thomas P. Peacock (6536120)</dc:creator>
          <dc:creator>Kelvin Lau (1847764)</dc:creator>
          <dc:creator>Katie J. Doores (346210)</dc:creator>
          <dc:creator>Dalan Bailey (193037)</dc:creator>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>multiple bat coronaviruses</dc:subject>
          <dc:subject>g ., rc</dc:subject>
          <dc:subject>g ., civet</dc:subject>
          <dc:subject>clade 1 viruses</dc:subject>
          <dc:subject>restricted ace2 usage</dc:subject>
          <dc:subject>mammalian ace2 proteins</dc:subject>
          <dc:subject>g ., rhgb07</dc:subject>
          <dc:subject>using monoclonal antibodies</dc:subject>
          <dc:subject>clade 1 sarbecoviruses</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>determined host range</dc:subject>
          <dc:subject>converting enzyme 2</dc:subject>
          <dc:subject>2 convalescent individuals</dc:subject>
          <dc:subject>ace2 ), via</dc:subject>
          <dc:subject>using binding assays</dc:subject>
          <dc:subject>antigenicity using sera</dc:subject>
          <dc:subject>related bat sarbecoviruses</dc:subject>
          <dc:subject>using sarbecoviruses</dc:subject>
          <dc:subject>host range</dc:subject>
          <dc:subject>clade 3</dc:subject>
          <dc:subject>pangolin ),</dc:subject>
          <dc:subject>neutralising antibodies</dc:subject>
          <dc:subject>entry assays</dc:subject>
          <dc:subject>binding domain</dc:subject>
          <dc:subject>sarbecoviruses interact</dc:subject>
          <dc:subject>sarbecoviruses exhibited</dc:subject>
          <dc:subject>rodent ace2</dc:subject>
          <dc:subject>like rhgb07</dc:subject>
          <dc:subject>generalist ace2</dc:subject>
          <dc:subject>related antigenicity</dc:subject>
          <dc:subject>zoonotic potential</dc:subject>
          <dc:subject>vitally important</dc:subject>
          <dc:subject>still evidence</dc:subject>
          <dc:subject>specialist &lt;/</dc:subject>
          <dc:subject>shifting pattern</dc:subject>
          <dc:subject>robust evidence</dc:subject>
          <dc:subject>research indicates</dc:subject>
          <dc:subject>racoon dog</dc:subject>
          <dc:subject>novel structure</dc:subject>
          <dc:subject>largely maintained</dc:subject>
          <dc:subject>including human</dc:subject>
          <dc:subject>immunodominant target</dc:subject>
          <dc:subject>human primate</dc:subject>
          <dc:subject>generalist phenotypes</dc:subject>
          <dc:subject>generalist &lt;/</dc:subject>
          <dc:subject>especially omicron</dc:subject>
          <dc:subject>entry phenotypes</dc:subject>
          <dc:subject>diverse panel</dc:subject>
          <dc:subject>continued evolution</dc:subject>
          <dc:subject>breakthrough infections</dc:subject>
          <dc:description>&lt;p&gt;&lt;b&gt;(A)&lt;/b&gt; Heatmap showing the receptor usage of bat sarbecovirus-pseudotyped viruses with mammalian ACE2s, including human, livestock/pets, rodents, potential intermediate hosts and monkeys. The mean log RLU from 3 separate experiments is shown and a pDISPLAY control to illustrate the background levels of entry. &lt;b&gt;(B)&lt;/b&gt; Surface representation of human ACE2 coloured with mammalian ACE2 conservation (human ACE2: PDB 6M0J), with the outlined region denoting the RBD-interacting sites, with individual amino acids labelled. &lt;b&gt;(C)&lt;/b&gt; WebLogo (University of California, Berkley, USA) plots summarising the amino acid divergence within the mammalian ACE2 sequences used in this screen. The single-letter amino acid code is used with the vertical height presenting the relative frequency of that amino acid at each position. The positions at which ACE2 interacts with SARS-CoV-2 RBD are shown, N-terminal to C-terminal, with different colours representing amino acid conservation between the mammalian ACE2s examined in this study. The data underlying this Figure can be found in &lt;a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003944#pbio.3003944.s017" target="_blank"&gt;S1 Data&lt;/a&gt;.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T17:40:07Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pbio.3003944.g003</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Bat_sarbecovirus_usage_of_mammalian_ACE2_p_/34047373</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
